Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $9.1950 (-3.26%) ($9.1950 - $9.1950) on Thu. Feb. 11, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.97% (three month average) | RSI | 56 | Latest Price | $9.1950(-3.26%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.8% a day on average for past five trading days. | Weekly Trend | BCRX advances 3.3% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(43%) IBB(39%) IWC(37%) IWO(37%) IWM(36%) | Factors Impacting BCRX price | BCRX will decline at least -3.485% in a week (0% probabilities). VIXM(-20%) UUP(-15%) VXX(-7%) IGOV(-4%) TBT(-2%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.485% (StdDev 6.97%) | Hourly BBV | -1.7 () | Intraday Trend | 0% | | | |
|
Resistance Level | $9.48 | 5 Day Moving Average | $9.72(-5.4%) | 10 Day Moving Average | $9.93(-7.4%) | 20 Day Moving Average | $9.48(-3.01%) | To recent high | -22.7% | To recent low | 82.6% | Market Cap | $1.622b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |